What is the most common location of Basal Cell Carcinoma (BCC) in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Most Common Location of Basal Cell Carcinoma

The most common location of basal cell carcinoma (BCC) is the head and neck region, specifically sun-exposed areas of the face, with the lower eyelid being the single most frequently affected site within the periocular area. 1

Anatomic Distribution

Primary Sites

  • Head and neck region accounts for 29-54% of all BCCs, representing the highest-risk anatomic area 2
  • Within the head and neck, the central face ("mask area" or "H-zone") carries the highest risk, encompassing:
    • Eyes, nose, lips, and ears 1
    • Eyelids, eyebrows, periorbital skin 3
    • Chin, mandible, and preauricular areas 3

Periocular Distribution Specifically

  • Lower eyelid: 55-61.5% of periocular BCCs 4, 5
  • Inner (medial) canthus: 17.9-19% 4, 5
  • Upper eyelid: 12.8-17% 4, 5
  • Outer (lateral) canthus: 7.6-9% 4, 5

Geographic and Demographic Variations

Regional Differences

  • Older UK-based studies reported 60-85% of BCCs on the lower legs, particularly in women, reflecting different sun exposure patterns in countries with lower sunshine rates 6
  • This contrasts with more recent data showing head and neck predominance globally 2

Gender-Specific Patterns

  • Lower limbs are affected more frequently in women than men 6
  • The overall male-to-female ratio shows slight female preponderance in most studies 6

Clinical Significance of Location

High-Risk "Mask Area" Concept

The high-risk facial zone concept, established since 1983, is based on a 27-year NYU retrospective review of 5,755 BCCs showing significantly higher recurrence rates in central facial locations 2, 7

Size-Location Interaction

  • Tumors ≥6 mm in high-risk locations (central face) have significantly increased recurrence risk 2, 7
  • Tumors ≥10 mm in moderate-risk locations show elevated recurrence rates 2, 7

Etiologic Correlation

UV radiation exposure is the primary driver of anatomic distribution, with sun-exposed head and neck sites bearing the highest burden 1, 2. Childhood sun exposure appears particularly important in determining later BCC development 1.

Uncommon Locations

While rare, BCCs can occur in sun-protected areas including nasal vestibule, interdigital spaces, axillae, nipples, and genital/perianal regions, typically related to non-UV factors such as arsenic exposure or radiation therapy 8

Clinical Pitfall

Do not dismiss lesions in atypical locations - while head and neck predominates, BCCs can develop anywhere, and location alone should not exclude the diagnosis 8. The lower eyelid's prominence as the single most common periocular site makes this area particularly important during skin examinations 4, 5.

References

Guideline

guidelines for the management of basal cell carcinoma.

British Journal of Dermatology, 2008

Guideline

basal cell skin cancer, version 1.2016, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Guideline

Basal Cell Carcinoma Characteristics and Risk Factors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Periocular basal cell carcinoma: demographic, clinical, histological and immunohistochemical evaluation of a series of 39 cases.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2019

Guideline

basal cell and squamous cell skin cancers.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Research

Basal Cell Carcinoma in the Nasal Vestibule.

Journal of drugs in dermatology : JDD, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.